BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2011
View Archived Issues
Pfizer offers overview of second quarter 2011
Read More
Sanofi discovers new lysophospholipid S1P1 receptor agonists
Read More
Axin-2 as a key regulator of remyelination
Read More
MSX-1 missense substitution linked to familial hypodontia
Read More
New voltage-gated calcium channel blockers synthesized
Read More
Novel chalcone-linked imidazolone compounds disclosed by CSIR
Read More
Addex patents novel metabotropic glutamate mGlu4 receptor modulators
Read More
Theravance presents new norepinephrine/serotonin reuptake inhibitors
Read More
Palatin Technologies confirms commencement of phase I trial of AZD-2820
Read More
AAA obtains rights to anticancer antibody fragment from Dompe
Read More
CBio presents data from phase IIa XToll trial in rheumatoid arthritis
Read More
Repros Therapeutics reports data from Androxal study in men with type 2 diabetes
Read More
Victrelis obtains approval in Canada for chronic hepatitis C
Read More
Decitabine plus carboplatin shows promise in phase II ovarian cancer trial
Read More
MMRF and Onyx launch carfilzomib expanded access program
Read More
Trius Therapeutics reaches agreement with FDA for phase III torezolid trial
Read More
Chains of magnetasomes show antitumor effects in preclinical study
Read More
MolMed to develop production process for gene therapy for GSK
Read More
Alexza resubmits NDA to FDA for AZ-004
Read More
Axanum obtains positive agreement for E.U. approval
Read More
Genmab reports topline results for ofatumumab in aggressive lymphoma
Read More
FDA continues review of EUSA Pharma's BLA for Erwinaze in acute lymphoblastic leukemia
Read More
Amgen presents highlights of second quarter 2011
Read More
STATegics receives grant to advance product candidates for Friedreich's ataxia
Read More
